Niro Ananda is a corporate advisory / M&A lawyer who specialises in advising private equity clients and their portfolio companies across all types of M&A transactions, including private and public M&A, securities offerings and capital restructures.

His clients include some of Australia's largest private equity firms such as Ironbridge Capital, Pacific Equity Partners, Archer Capital and Quadrant Private Equity as well as global private equity firms and financial sponsors such as Bain Capital, Providence Equity Partners and Intermediate Capital Group.

Niro has expertise in a wide range of industries including IT, retail, health, manufacturing and FMCG, having advised private equity portfolio company clients as well as corporate clients in those industries.

Read More

Expertise

Expand all

Private Equity

MYOB Group: Niro advised MYOB on the A$2 billion takeover offer from private equity firm KKR & Co. Niro is long-time adviser to MYOB, having acted as Australian Counsel to Bain Capital on its A$1.2 billion acquisition from a consortium led by Archer Capital and its subsequent exit through a successful IPO and ASX listing.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its acquisition of Evolution Healthcare.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its joint venture with Landis + Gyr and acquisition of the Origin's smart metering business.

Intermediate Capital Group: Niro advised Intermediate Capital Group on its management buy-out of CHAMP Ventures owned RSEA. Niro also acted for Intermediate Capital Group on both its initial MBO of Cura Day Hospitals Group as well as its successful exit via a sale to German medical giant, Fresenius, which valued Cura at $450 million.

Odyssey Private Equity: Niro advised Odyssey Private Equity on its acquisition of Mine Site Technologies.

Emergent Cold: Niro advised Emergent Cold (and its financial sponsor shareholder) on its acquisition of the Swire Cold Storage business. Niro also advised on subsequent acquisitions in Australia and Asia (2018).

ROC Partners: Niro advised Roc Partners on the establishment of a special purpose fund which was used to acquire a majority interest in Stone Axe Pastoral Pty Ltd. as well as further bolt on acquisitions (2017-2019).

Bain Capital: Niro advised Bain Capital on its block trades in MYOB as well as its bid for GenesisCare and ALS Limited

See Private Equity

Corporate / M&A

MYOB Group: Niro advised MYOB on the A$2 billion takeover offer from private equity firm KKR & Co. Niro is long-time adviser to MYOB, having acted as Australian Counsel to Bain Capital on its A$1.2 billion acquisition from a consortium led by Archer Capital and its subsequent exit through a successful IPO and ASX listing.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its acquisition of Evolution Healthcare.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its joint venture with Landis + Gyr and acquisition of the Origin's smart metering business.

Intermediate Capital Group: Niro advised Intermediate Capital Group on its management buy-out of CHAMP Ventures owned RSEA. Niro also acted for Intermediate Capital Group on both its initial MBO of Cura Day Hospitals Group as well as its successful exit via a sale to German medical giant, Fresenius, which valued Cura at $450 million.

Odyssey Private Equity: Niro advised Odyssey Private Equity on its acquisition of Mine Site Technologies.

Emergent Cold: Niro advised Emergent Cold (and its financial sponsor shareholder) on its acquisition of the Swire Cold Storage business. Niro also advised on subsequent acquisitions in Australia and Asia (2018).

ROC Partners: Niro advised Roc Partners on the establishment of a special purpose fund which was used to acquire a majority interest in Stone Axe Pastoral Pty Ltd. as well as further bolt on acquisitions (2017-2019).

Bain Capital: Niro advised Bain Capital on its block trades in MYOB as well as its bid for GenesisCare and ALS Limited.

See Corporate / M&A

Mergers and Acquisitions

MYOB Group: Niro advised MYOB on the A$2 billion takeover offer from private equity firm KKR & Co. Niro is long-time adviser to MYOB, having acted as Australian Counsel to Bain Capital on its A$1.2 billion acquisition from a consortium led by Archer Capital and its subsequent exit through a successful IPO and ASX listing.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its acquisition of Evolution Healthcare.

Pacific Equity Partners: Niro advised Pacific Equity Partners on its joint venture with Landis + Gyr and acquisition of the Origin's smart metering business.

Intermediate Capital Group: Niro advised Intermediate Capital Group on its management buy-out of CHAMP Ventures owned RSEA. Niro also acted for Intermediate Capital Group on both its initial MBO of Cura Day Hospitals Group as well as its successful exit via a sale to German medical giant, Fresenius, which valued Cura at $450 million.

Odyssey Private Equity: Niro advised Odyssey Private Equity on its acquisition of Mine Site Technologies.

Emergent Cold: Niro advised Emergent Cold (and its financial sponsor shareholder) on its acquisition of the Swire Cold Storage business. Niro also advised on subsequent acquisitions in Australia and Asia (2018).

ROC Partners: Niro advised Roc Partners on the establishment of a special purpose fund which was used to acquire a majority interest in Stone Axe Pastoral Pty Ltd. as well as further bolt on acquisitions (2017-2019).

Bain Capital: Niro advised Bain Capital on its block trades in MYOB as well as its bid for GenesisCare and ALS Limited. 

See Mergers and Acquisitions

Equity Capital Markets

Bravura Solutions: Niro advised Bravura, an industry leading supplier of software / technology solutions and services, on a dual track trade sale/IPO process. Ultimately the deal was completed by way of an IPO with a market capitalisation of A$350 million (2016).

MYOB Group: Niro advised on its initial public offering and ASX listing with a market capitalisation of over A$2 billion, making it the largest IPO to have launched in the Australian market to date in 2015 and the largest technology IPO on the ASX (2015).

Monash IVF Group Limited/Ironbridge Capital: Niro advised Monash and its major shareholder Ironbridge Capital on its A$427.5 million initial public offering (2014).

Pacific Equity Partners: advised in respect of the A$1.75 billion IPO of Spotless Group Holdings Limited (2014).

Private equity block trades: Niro has advised leading private equity firms such as Pacific Equity Partners, Bain Capital and Ironbridge Capital on block trades valued in aggregate in excess of $3 billion.

See Equity Capital Markets/IPOs

Knowledge

    Related knowledge information is loading